leadf
logo-loader
viewCanntab Therapeutics Ltd
(
CSE:PILLOTCQB:CTABF
)

Canntab sign deal with World Class Extractions to use the “Boss” machine

Canntab Therapeutics (CSE: PILL) CFO Richard Goldstein sat down with Steve Darling from Proactive Vancouver to discuss the company signing a deal with World Class Extractions to provide equipment in their production facilities.

Goldstein telling Proactive why having a company in-house instead of a third party company make much more financial sense.

Quick facts: Canntab Therapeutics Ltd

Follow
CSE:PILL

Price: 0.7 CAD

Market Cap: $24.89 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of named herein, including the promotion by the Company of in any Content on the Site, the Company receives from said issuer annual cash...

FOR OUR FULL DISCLAIMER CLICK HERE

Destiny Pharma Presenting at the One2One Virtual Forum - 16th September 2021

Destiny Pharma is a clinical phase biotechnology company dedicated to the development of novel anti-infectives with a focus on infection prevention. The Company is developing novel antimicrobial drugs from its “in-house” XF platform and also from recently acquired Biotherapeutic products that...

3 days, 10 hours ago

2 min read